The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect size as a tool to identify subpopulations with improved clinical outcomes in metastatic colorectal cancer.
 
Stephanie Leigh Fricke
No Relationships to Disclose
 
Jeremy D. Kratz
No Relationships to Disclose
 
Noelle K. LoConte
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene
 
Sam Joseph Lubner
Employment - Mitra Biotech; Mitra Biotech; Mitra Biotech; Mitra Biotech
Leadership - Mitra Biotech; Mitra Biotech; Mitra Biotech; Mitra Biotech
 
Daniel Mulkerin
No Relationships to Disclose
 
Kristina A. Matkowskyj
No Relationships to Disclose
 
Jens C. Eickhoff
Consulting or Advisory Role - Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics
Research Funding - Sanofi Pasteur (Inst); Sanofi Pasteur (Inst); Sanofi Pasteur (Inst); Sanofi Pasteur (Inst)
 
Dustin A. Deming
Consulting or Advisory Role - Acrotech Biopharma; Acrotech Biopharma; Acrotech Biopharma; Acrotech Biopharma; Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Novocure; Novocure; Novocure; Novocure; Promega; Promega; Promega; Promega; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)